Why We Need Generic Medicines Part 3: Patient Impact and Relative Use Across Therapy Areas

In Part 3 we explore how the availability of Generic Medicines in Europe has resulted in one of three potential benefits for patients in each country, whilst Generic Medicines have also come to dominate 10 key therapeutic areas by volume use.

To download the Why We Need Generic Medicines Part 3: Patient Impact and Relative Use Across Therapy Areas report, please fill out the form:

Required*